Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug:228:212-219.
doi: 10.1016/j.ajo.2021.03.048. Epub 2021 May 11.

Classification Criteria for Sympathetic Ophthalmia

Collaborators

Classification Criteria for Sympathetic Ophthalmia

Standardization of Uveitis Nomenclature (SUN) Working Group. Am J Ophthalmol. 2021 Aug.

Abstract

Purpose: The purpose of this study was to determine classification criteria for sympathetic ophthalmia.

Design: Machine learning of cases with sympathetic ophthalmia and 5 other panuveitides.

Methods: Cases of panuveitides were collected in an informatics-designed preliminary database, and a final database was constructed of cases achieving supermajority agreement on the diagnosis using formal consensus techniques. Cases were split into a training set and a validation set. Machine learning using multinomial logistic regression was used in the training set to determine a parsimonious set of criteria that minimized the misclassification rate among the panuveitides. The resulting criteria were evaluated in the validation set.

Results: A total of 1,012 cases of panuveitides, including 110 cases of sympathetic ophthalmia, were evaluated by machine learning. The overall accuracy for panuveitides was 96.3% in the training set and 94.0% in the validation set (95% confidence interval: 89.0-96.8). Key criteria for sympathetic ophthalmia included bilateral uveitis with 1) a history of unilateral ocular trauma or surgery and 2) an anterior chamber and vitreous inflammation or a panuveitis with choroidal involvement. The misclassification rates for sympathetic ophthalmia were 4.2% in the training set and 6.7% in the validation set.

Conclusions: The criteria for sympathetic ophthalmia had a low misclassification rate and appeared to perform sufficiently well for use in clinical and translational research.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Douglas A. Jabs: none; Andrew Dick: consultant: AbbVie, Alimera, Apitope, Astellas, Gyroscope, Janssen, Roche; James P. Dunn: none; Michal Kramer: none; Cristina Muccioli: none; Neal Oden: none; Annabelle A. Okada: consultant: AbbVie Japan, Astellas Pharma Japan, Bayer AG, Daiichi Sankyo; lecture fees: Alcon Pharm Japan, Mitsubishi Tanabe Pharma, Novartis Pharma Japan, Santen Pharmaceutical Corporation, Senju Pharmaceutical Corporation; grant support from Alcon Pharma Japan, Bayer Yakuhin, Mitsubishi Tanabe Pharma; Alan G. Palestine: none; Narsing A. Rao: none; Jennifer E. Thorne: Dr. Thorne engaged in a part of this research as a consultant and was compensated for the consulting service; Brett E. Trusko: none.

References

    1. Mackenzie W A Practical treatise on the Diseases of the Eye. 3rd edition. Longmans, London, 1840. pp. 523–34.
    1. Makley TA, Azar A. Sympathetic ophthalmia: a long-term follow-up. Arch Ophthalmol 1978;257–62. - PubMed
    1. Marak GE. Recent advances in sympathetic ophthalmia. Surv Ophthalmol 1979;24:141–56. - PubMed
    1. Lubin JR, Albert DM, Weinstein M. Sixty-five years of sympathetic ophthalmia. A clinicopathologic review of 105 cases (1913–1978). Ophthalmology 1980;87:109–21. - PubMed
    1. Kilmartin DJ, Dick AD, Forrester JV. Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland. Br J Ophthalmol 2000;84:259–63. - PMC - PubMed

Publication types

LinkOut - more resources